Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,142
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 13,921–13,940 of 18,028 recalls

FDA Recall Terminated Historical recordClass II

Dextrose Injection, USP, 20%, Packaged as 500 mL in 1000 mL Bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7935-19, Barcode (01) 0 030409 793519 2

by Hospira Inc.

Reason
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
Published
April 27, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextrose Injection, USP, 50%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7936-19, Barcode (01) 0 030409 793619 9

by Hospira Inc.

Reason
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
Published
April 27, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextrose Injection, USP, 70%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7918-19, Barcode (01) 0 030409 791819 5

by Hospira Inc.

Reason
Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.
Published
April 27, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Sulfate Tablets USP, 5 mg, 100-count bottle, Rx only, Manufactured and Distributed by: CorePharma, LLC, Middlesex, NJ 08846, NDC 64720-215-10

by Impax Laboratories, Inc.

Reason
Failed Impurities/Degradation Specifications
Published
April 27, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Sulfate Tablets USP, 10 mg, 100-count bottle, Rx only, Manufactured and Distributed by: Corepharma, LLC, Middlesex, NJ 08846, NDC 64720-0216-10

by Impax Laboratories, Inc.

Reason
Failed Impurities/Degradation Specifications
Published
April 27, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Telmisartan Tablets, USP, 80 mg, 30-count (3 x 10 unit-dose blisters) per carton, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, Dist. Mehsana, INDIA.; For: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, NDC 13668-158-72, UPC 3 13668 158 72 4.

by Torrent Pharmaceuticals Limited

Reason
Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.
Published
April 27, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fenofibrate Capsules (Micronized), 200 mg , 30-count Unit Dose Blister Packs per carton, Rx Only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 Carton of 30:NDC 68084-835-32, Individual Dose: NDC 68084-835-33.

by Amerisource Health Services

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Published
April 20, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fenofibrate Capsules (Micronized), 134 mg Capsules, 20-count Unit Dose Blister Packs per carton, Rx Only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217, Carton of 20: NDC 68084-835-32, Individual Dose: NDC 68084-835-33.

by Amerisource Health Services

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Published
April 20, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fenofibrate Capsules (Micronized) 200 mg, 500-count bottle, Rx Only, Distributed by Impax Generics, Hayward, CA 94544, NDC 0115-0533-02

by Impax Laboratories, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp. Date
Published
April 20, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fenofibrate Capsules (Micronized) 134 mg, 500-count bottle, Rx Only, Distributed by Impax Generics, Hayward, CA 94544, NDC 0115-0522-02

by Impax Laboratories, Inc.

Reason
Labeling: Incorrect or Missing Lot and/or Exp. Date
Published
April 20, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial, Rx only, Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-417-10

by Fresenius Kabi USA, LLC

Reason
Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative.
Published
April 20, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Haloperidol Decanoate Injection, 50 mg/mL, 1 mL vial, Rx Only. Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-469-01.

by Fresenius Kabi USA, LLC

Reason
Failed Impurities/Degradation Specifications: Firm is recalling product due to an impurity out-of-specification result.
Published
April 20, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 5 mg, 100 ct. bottle, Rx Only. Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-743-11.

by Actavis Elizabeth LLC

Reason
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Published
April 13, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 30 mg, 100 ct. bottle, Rx Only. Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-749-11.

by Actavis Elizabeth LLC

Reason
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Published
April 13, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 20 mg, 100 ct. bottle, Rx Only. Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-748-11.

by Actavis Elizabeth LLC

Reason
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Published
April 13, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 10 mg, 100 ct. bottle, Rx Only. Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-745-11.

by Actavis Elizabeth LLC

Reason
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Published
April 13, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05

by Jubilant Draximage Inc

Reason
Labeling: Label Error on Declared Strength
Published
April 13, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Minocycline Hydrochloride Capsules USP, 100 mg*, 30 Capsules (3 x 10) Unit Dose blisters (NDC 50268-569-11, barcode 5026856911) per carton (NDC 50268-569-13, barcode 5026856913), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478.

by Apace KY LLC

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of 13650.
Published
April 13, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottle, Rx only, Mfd For: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724, NDC 23155-291-51

by Bio-pharm, Inc.

Reason
Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.
Published
April 13, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Formula 2 (Papaverine 9 mg, Phentolamine 1 mg, Atropine 0.1 mg, PGE 10 mcg/mL), 5 mL vials, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.

by Meditech Laboratories, Inc

Reason
Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.
Published
April 13, 2016
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.